metoprolol has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 6 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recurrence was noted to occur within 2 months of therapy." | 5.46 | Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. ( Ermakov, S; Gerstenfeld, EP; Scheinman, MM; Svetlichnaya, Y, 2017) |
| "Recurrence was noted to occur within 2 months of therapy." | 1.46 | Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. ( Ermakov, S; Gerstenfeld, EP; Scheinman, MM; Svetlichnaya, Y, 2017) |
| "Colchicine has anti-inflammatory and anti-fibrotic properties." | 1.39 | An unusual form of Naxos disease and its improvement by adjuvant low-dose colchicine therapy. ( Gultekin, N; Kucukates, E, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erolu, E | 1 |
| Akalın, F | 1 |
| Saylan Çevik, B | 1 |
| Yücelten, D | 1 |
| Gultekin, N | 1 |
| Kucukates, E | 1 |
| Ermakov, S | 1 |
| Gerstenfeld, EP | 1 |
| Svetlichnaya, Y | 1 |
| Scheinman, MM | 1 |
| Hariman, RJ | 1 |
| Khin, MM | 1 |
| Zoble, RG | 1 |
| Wellemeyer, K | 1 |
| Röthemeyer, S | 1 |
| Kranig, W | 1 |
| Grove, R | 1 |
| Thale, J | 1 |
| Markiewicz-Łoskot, G | 1 |
| Moric-Janiszewska, E | 1 |
| Loskot, M | 1 |
| Szydłowski, L | 1 |
| Hollek, A | 1 |
| Weglarz, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Randomized Trial With Flecainide in ARVC Patients[NCT03685149] | Phase 2 | 23 participants (Actual) | Interventional | 2019-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for metoprolol and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Arrhythmogenic right ventricular dysplasia, cutaneous manifestations and desmoplakin mutation: Carvajal syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arrhythmogenic Rig | 2018 |
An unusual form of Naxos disease and its improvement by adjuvant low-dose colchicine therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arrhythmogenic Right Ventricular Dysplasia; Colchicine | 2013 |
Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Catheter Ablation; Combin | 2017 |
Wide QRS Tachycardia in a young patient.
Topics: Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Blood Pressure; Defibrillators, | 2012 |
[The arrhythmogenic right ventricular cardiomyopathy (ARVC)].
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Cardiac Complexes, Premat | 2003 |
Arrhythmogenic right ventricular dysplasia:clinical study.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Catheter | 2007 |